Showing 1 - 10 of 61,040
The COVID-19 crisis intensified decade-long debates on the interaction between intellectual property rights (IPRs), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a tried-and-tested method to expand access, particularly...
Persistent link: https://www.econbiz.de/10014541546
This article investigates interpretative difficulty in compulsory licensing dispute by taking the Thailand case of …
Persistent link: https://www.econbiz.de/10014167418
Despite multilateral commitments and political statements of solidarity and cooperation to guarantee the availability and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the beginning of vaccination is marked by the deepening of vaccine...
Persistent link: https://www.econbiz.de/10012496070
Persistent link: https://www.econbiz.de/10012433890
Persistent link: https://www.econbiz.de/10003744317
Persistent link: https://www.econbiz.de/10010252986
Persistent link: https://www.econbiz.de/10011406699
In this paper, the author argues that compulsory licenses might potentially amount to indirect expropriation provided that their effects constitute a severe curtailment of the patent rights. Inasmuch as the expropriation standards in BIAs differ from those articulated under the TRIPS Agreement,...
Persistent link: https://www.econbiz.de/10013069275
The World Trade Organization (WTO) linked intellectual property protection with trade. The WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), however, included a number of public health flexibilities in order to provide latitude to the Member States to...
Persistent link: https://www.econbiz.de/10013258010
Persistent link: https://www.econbiz.de/10012439755